Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context. Although tremendous progress ha...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmaceutics
Auteurs principaux: Karim, Md. Emranul, Tha, Kyi Kyi, Othman, Iekhsan, Borhan Uddin, Mohammad, Chowdhury, Ezharul Hoque
Format: Artigo
Langue:Inglês
Publié: MDPI 2018
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026921/
https://ncbi.nlm.nih.gov/pubmed/29861465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics10020065
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires